Paclitaxel Injection Solution 30 mg - 100 mg - 150 mg - 300 mg

Return to Oncological Line Products

Products with Certified Quality

Name of the product: DALYS 30

Active ingredient: Paclitaxel 30 mg

Dosage form: injection solution

Name of the product: DALYS 100

Active ingredient: Paclitaxel 100 mg

Dosage form: injection solution

Name of the product: DALYS 150

Active ingredient: Paclitaxel 150 mg

Dosage form: injection solution

Name of the product: DALYS 300

Active ingredient: Paclitaxel 300 mg

Dosage form: injection solution

Dispensing requirements: Rx only

Argentine Industry

Composition:

Each millilitre of solution contains paclitaxel 6 mg, plyoxyethylated castor oil (Cremophor EL) and absolute alcohol.

Indications:

DALYS is indicated for the treatment of breast and ovary cancer, and for the treatment of metastasic ovarian carcinoma after the first-line and subsequent therapy have failed.

Therapeutic action:

Antineoplastic.

Storage:

Keep at temperature less than 25º C, in the marketed packing.

Marketed presentations:

DALYS 30 (paclitaxel 30 mg/5 ml):

Packs containing 1, 5 and 10 glass bottles.

Packs containing 100 glass bottles, for use in hospitals.

DALYS 100 (paclitaxel 100 mg/16.7 ml):

Packs containing 1, 5 and 10 glass bottles.

Packs containing 100 glass bottles, for use in hospitals.

DALYS 150 (paclitaxel 150 mg/25 ml):

Packs containing 1, 5 and 10 glass bottles.

Packs containing 100 glass bottles, for use in hospitals.

DALYS 300 (paclitaxel 300 mg/50 ml):

Packs containing 1, 5 and 10 glass bottles.

Packs containing 100 glass bottles, for use in hospitals.

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 46255

Laboratorio DOSA S.A.

Girardot 1369, (C1427AKC) Buenos Aires, Argentine

Pharmaceutical Director: María C. Terzo, Pharmacist